SadhnaRVoraMD
Oncology • North Waltham, MASenior Physician Editor, UpToDate; Instructor in Medicine, Harvard Medical School
Dr. Vora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
52 Second Avenue
Suite 1110
North Waltham, MA 02451Phone+1 781-487-6100
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2009 - 2012
Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
Yale School of MedicineClass of 2006
Certifications & Licensure
MA State Medical License 2008 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsErratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine ...Moshe Elkabets, Sadhna Vora, Dejan Juric, Natasha Morse, Mari Mino-Kenudson
Science Translational Medicine. 2018-11-14 - 343 citationsCDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K InhibitorsSadhna Vora, Dejan Juric, Nayoon Kim, Mari Mino-Kenudson, Tiffany Huynh
Cancer Cell. 2014-07-14 - 257 citationsmTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast CancerMoshe Elkabets, Sadhna Vora, Dejan Juric, Natasha Morse, Mari Mino-Kenudson
Science Translational Medicine. 2013-07-31
Press Mentions
Rio Bravo qWeekSeptember 25th, 2020
Recipients of AACR Research Funding & Fellowships 1993–2017September 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
